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Background: Respiratory tract infections (RTIs) are an important cause of death in children, and often contribute to
the terminal decline in children with chronic conditions. RTIs are often underrecorded as the underlying cause of
death; therefore the overall contribution of RTIs to child deaths and the potential preventability of RTI-related deaths
have not been adequately quantified.
Methods: We analysed deaths in children resident in England who died of non-injury causes aged 28 days to
18 years between 2001 and 2010 using death certificates linked to a longitudinal hospital admission database.
We defined deaths as RTI-related if RTIs or other respiratory conditions were recorded on death certificates or linked
hospital records up to 30 days before death. We examined trends in mortality by age group, year and season
(winter or summer) and determined the winter excess of RTI-related deaths using rate differencing techniques.
We estimated the proportion of RTI-related deaths in children with chronic conditions.
Results: 22.4% (5039/22509) of child deaths were RTI-related. RTI-related deaths declined by 2.3% per year in infants
aged 28 to 364 days between 2001 and 2010. No decline was observed for older children. On average there were
161 winter excess RTI-related deaths annually, accounting for 32% of all RTI-related deaths. 89.0% of children with
RTI-related deaths had at least one chronic condition; neurological conditions were the most prevalent.
Conclusions: RTI-related deaths have not declined in the last decade except in infants. Targeted strategies to
prevent the winter excess of RTIs and to treat RTIs in children, particularly children with chronic conditions, may
reduce RTI-related deaths.
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Respiratory tract infections (RTIs) are an important
contributor to mortality in children worldwide [1-3].
Childhood mortality from respiratory conditions in
England and Wales declined by 85% to 92% between the
1960s and the 1990s [4]. Yet, research into the mortality
burden of specific pathogens have shown that influenza
and respiratory syncytial virus (RSV) are estimated to
cause up to 500 deaths in children in England and Wales
every year [5,6]. This is despite national influenza and
passive RSV vaccination programmes targeted at children
deemed at high risk [7]. In 2009/10, three years after the
introduction of seven-valent pneumococcal vaccine, 17
deaths per year were estimated to occur due to invasive* Correspondence: p.hardelid@ucl.ac.uk
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Few studies have examined the overall contribution of RTIs
to childhood mortality, despite the importance to policy.
Quantifying the mortality burden of RTIs is not
straightforward. Many previous studies rely on death
certification data alone, however difficulties in accurately
determining and recording causes of death are well de-
scribed [9-11]. A further complication is that RTI-related
deaths often occur in people with complex health prob-
lems, in whom RTIs contribute to the terminal decline
[12]. It can therefore be difficult to determine whether the
RTI was a cause or a consequence of the underlying health
condition. This particularly becomes an issue when
attempting to infer what proportion of RTI deaths are pre-
ventable through improvements in care or public health
interventions such as vaccination.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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death certificates linked to electronic hospital admission
records from all non-injury deaths in children to define
deaths related to RTIs. Although the preventability of
RTI-related deaths cannot be directly estimated using
administrative data, we inferred preventability by looking
at trends over time in RTI-related deaths, contrasting
with trends in overall non-injury mortality, and estimat-
ing excess RTI-related deaths in winter. We also exam-
ine the proportion of RTI-related deaths that occur in
children with chronic conditions.
Methods
Data sources
We analysed death certificates linked to a longitudinal
hospital admission database for all resident children in
England who died of non-injury related causes, based on
their underlying cause of death, aged between 28 days and
18 completed years between January 2001 and December
2010. Linkage was carried out by the Trusted Data Link-
age Service of the Health and Social Care Information
Centre, using a deterministic algorithm based on NHS
number, date of birth, sex and postcode. The linkage
methods and accuracy are described in detail elsewhere
[13]. Upon receipt of the data, we checked and cleaned
them according to algorithms described previously [14].
The dataset included late-registered deaths until 7th Au-
gust 2012. Hospital admission records were obtained from
the Hospital Episode Statistics (HES) database [15] and
included any admissions to National Health Service (NHS)
hospitals in England from April 1997. Death certificates
and hospital records were coded using the International
Classification of Diseases version 10 (ICD-10). Information
on prescribing is not available in HES. Population denomi-
nators by age and year were obtained from the Office for
National Statistics.
Ethics
All identifiers used for linkage were removed before data
was sent to us. The data we used for the study were there-
fore anonymised, without personal identifiers. The data
were collected as part of routine clinical practice or vital
registration processes, not for research. Following guid-
ance from the NHS Health Research Authority on using
anonymised data collected as part of routine clinical prac-
tice for research purposes, [16] we did not seek ethical
review of this study.
Definition of RTI-related deaths and chronic conditions
Since RTIs are likely to be variably coded in administrative
health databases, we chose a broad definition of RTI-
related deaths to minimise undercounting. We identified
RTI-related deaths using ICD-10 codes A37, J00-J22,
which are specific for acute RTIs, based on codes listedanywhere on death certificates, or hospital discharge
records where the date of the start of the hospital epi-
sode (an episode is a period of continuous care under
one consultant [15]) was up to 30 days before death.
We also conducted secondary analyses using a more
sensitive cluster of codes indicating any respiratory
condition, including RTIs (ICD-10 A37, J00-J99, R05,
R06, E84, P75, Q30-Q34, Q790, G47.3, P22-P28), in
children who died. The estimate of winter excess deaths
related to any respiratory condition defined by the sensi-
tive coding cluster could be interpreted as an upper bound
on the number of excess RTI-related deaths.
Chronic conditions were defined as any condition that
would require medical follow-up for one year or more,
based on ICD-10 codes on death certificates or in hospital
records up to one year before death [14]. Chronic condi-
tions were grouped into eight categories for analyses: men-
tal/behavioural, cancer/blood, chronic infection, respiratory,
endocrine/metabolic/renal/digestive/genitourinary, muscu-
loskeletal/skin, neurological/sensory and cardiac conditions.
Statistical analyses
All analyses were carried out according to age group at
death (28 to 364 days, one to four years and five to
18 years). We calculated annual RTI-related mortality
rates to examine trends over time. Poisson regression
models were fitted with year as a linear term to deter-
mine whether any observed trends in annual mortality
rates were statistically significant (defined as a likelihood
ratio test p <0.05) comparing an intercept only model
and a model including year). If the trend was significant,
possible change points were examined using piecewise
generalised linear models to determine the change point
location [17]. Since these models were not nested, we used
the Akaike Information Criterion (AIC) to determine
whether a model including a change point improved the
overall fit. We compared trends in RTI-related mortality
rates to those for all non-injury causes.
We assumed that some of the winter excess of RTI-
related deaths could potentially be prevented through
prompt identification and treatment (including with an-
tibiotics), effective management of chronic conditions
(such as enhanced care for children with breathing sup-
port), universal vaccination strategies with effective vac-
cines, or improved hygiene measures such as hand
washing. To examine seasonality we plotted weekly and
monthly mortality rates per 100,000 population. Monthly
rates were plotted using circular plots, using the season
library in R [18]. RTI mortality rates in winter (defined as
week 40 to week 20 the following year) and summer (week
21 to week 39) were calculated for the whole study period,
adjusting the population denominator to account for the
differing person-time at risk. This definition of a winter
period was chosen since it covers the weeks during which
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in England [19]. We estimated the number of excess RTI-
related deaths in winter periods compared with summer
periods using rate differencing techniques [6,20]. Further
details can be found in the Additional file 1. We calculated
the number of excess RTI-related deaths in winter as a
percentage of all RTI-related deaths, and as a percentage
of all non-injury deaths occurring in winter.
We calculated the proportion of RTI-related deaths that
occurred in children with chronic conditions, according to
type of chronic condition and age group. Denominators
for children with and without chronic conditions were not
available. Therefore we could not use rate differencing
techniques to estimate the number of excess RTI-related
deaths according to chronic condition type. Instead, we
compared the proportion of all RTI-related deaths which
occurred in winter in children with and without chronic
conditions respectively. We used χ2 tests to test for differ-
ences in the proportions of RTI-related deaths occurring
in children with chronic conditions. These analyses were
carried out using the RTI-specific code lists to define RTI-
related deaths.
Methods and results of sensitivity analyses are given in
the Additional file 1. All statistical analyses were carried
out in R version 3.0.1 [21].
Results
The study population comprised 22509 children who died
of non-injury causes between 2001 and 2010, of whom
9208 were aged between 28 and 364 days (40.9%), 4310
one to four years (19.1%) and 8991 five to 18 years
(39.9%). 14180 children (63.0%) were linked to at least one
hospital record within the last thirty days before death.
Overall, 3339 children who died of non-injury causes
had an RTI listed on their death certificate (14.8%), and
5039 children (22.4%) had an RTI listed on death certifi-
cates or on hospital records up to 30 days before death.
10169 children (45.2%) had at least one respiratory con-
dition (including RTIs and other respiratory conditions)
listed on their death certificates or on hospital records
up to 30 days before death. This was equivalent to 504
RTI-related deaths and 1017 any respiratory condition-
related deaths per year respectively. 18443 children had
at least one chronic condition (81.9%).
Recording of RTIs and respiratory conditions on death
certificates and hospital records was generally non-specific
(Additional file 1: Table S1), that is, not mentioning spe-
cific pathogens. There was weak agreement between hos-
pital records and death certificates in recording of any
respiratory condition (Additional file 1: Table S2); with
only 66.1% agreement for children who died in hospital.
Mortality rates for RTIs and other respiratory conditions
were between two and eight times higher when including
all causes listed on death certificates and linked hospitalrecords up to one month before death compared to using
the underlying cause only (Additional file 1: Table S3).
Annual trends in mortality rates from RTIs
Results from the Poisson regression models showed that
RTI-related deaths declined significantly between 2001
and 2010 by an average of 2.3% per year (95% CI 0.6%,
4.0%) in children aged between 28 and 364 days, as
shown in Figure 1 (LR test p = 0.01 for year as a linear
trend compared to intercept only model). This
amounted to a total decline of 28.9% between 2001 (a
mortality rate of 30.1/100,000 population) and 2010
(when the mortality rate had declined to 21.4/100,000
population). We detected a change point in the series in
2003, prior to which the decline was more pronounced.
No significant declines were observed for RTI-related
deaths in older children. No trends were observed for
deaths mentioning any respiratory condition in any age
group. In contrast, non-injury all-cause mortality rates
showed significant annual declines of 2.2% in children aged
28 to 364 days, 2.4% in one to four year olds and 2.6% in
five to 18 year olds during the same period (Figure 1).
Estimation of excess winter RTI deaths
A seasonal pattern was observed for mortality involving re-
spiratory conditions, particularly for RTI-related deaths
(Figure 2 and Table 1). Mortality rates peaked in December
for both specific RTI-related mortality and for deaths
involving any respiratory condition, but seasonal variation
in respiratory mortality was particularly evident in one to
four year old children (Figures 3 and 4).
There were 161 excess winter RTI-related deaths in chil-
dren aged between 28 days and 18 years each year
(Table 1), accounting for 32% of all RTI-related deaths. If
the more sensitive indicator, excess deaths with any re-
spiratory condition mentioned, was used, up to 194 excess
winter RTI-related deaths occurred annually. Although
the highest RTI-related mortality rates were observed in
children aged less than one year, excess winter RTI-related
deaths accounted for up to 41% of the total number of
RTI-related deaths and up to 22% of all winter deaths in
one to four year olds (Table 1).
RTI-related deaths in children with chronic conditions
Among children whose deaths were RTI-related, 89.0%
of 5039 children had one or more chronic conditions,
compared to 79.9% of 17470 children who did not die
with an RTI (χ2 test p <0.001). The proportion of chil-
dren whose deaths were RTI-related who also had a
chronic condition increased with age. 79.3% of children
aged between 28 and 364 days (of a total of 1512 children),
89.9% of children aged one to four years (1411 children)
and 95.3% of five to 18 year old children (2116 children)
who died with RTIs had a chronic condition (χ2 test for
Figure 2 Mortality rates (per 100,000 population) by week of the year, age group for deaths involving RTIs and any respiratory condition.
Figure 1 Mortality rates (per 100,000 population) for RTIs, any respiratory condition and all non-injury causes by age group, 2001–2010.
Note different y-axis scales for children aged less than one year.
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Table 1 Mortality rates by season, rate differences (both per 100,000 population), and rate ratios comparing winter and summer, for children with RTIs only
and any respiratory condition, with winter excess deaths shown as estimated number and percentage of all non-injury winter deaths and all RTI-related
deaths, by age group and indicator used, England, 2001-2010
Indicator
used
Ratewinter
(95% CI)
Ratesummer
(95% CI)
Rate
ratiowinter/summer
(95% CI)
Rate
differencewinter-summer
(95% CI)†
Total number of excess
RTI-related deaths in
winter (range)*
Average number of excess
RTI-related deaths each
winter (range)*
Winter excess as %
of total non-injury
deaths in winter**
Winter excess as %
of total RTI-related
deaths***
28-364 days
RTIs only 28.7 (27.1, 30.5) 17.2 (15.5, 19.0) 1.68 (1.49, 1.88) 11.59 (9.19, 13.98) 454 (360, 548) 45 (36, 55) 7.3% 30.0%
Any respiratory
condition
74.4 (71.7, 77.1) 58.1 (54.9, 61.3) 1.28 (1.20, 1.37) 16.23 (12.08, 20.38) 636 (474, 799) 64 (47, 80) 10.2% 15.1%
1-4 years
RTIs only 7.3 (6.8, 7.7) 3.5 (3.1, 3.9) 2.08 (1.84, 2.37) 3.78 (3.20, 4.36) 576 (487, 664) 58 (49, 66) 18.8% 40.8%
Any respiratory
condition
10.5 (10.0, 11.0) 6.1 (5.6, 6.7) 1.71 (1.55, 1.89) 4.37 (3.63, 5.10) 665 (553, 776) 66 (55, 78) 21.8% 31.2%
5-18 years
RTIs only 2.8 (2.6, 2.9) 1.7 (1.6, 1.9) 1.60 (1.45, 1.76) 1.04 (0.84, 1.24) 583 (471, 695) 58 (47, 69) 9.6% 27.6%
Any respiratory
condition
4.8 (4.6, 4.9) 3.6 (3.4, 3.8) 1.32 (1.23, 1.41) 1.14 (0.87, 1.42) 640 (485, 794) 64 (49, 79) 10.6% 16.7%
All ages
RTIs only 5.0 (4.9, 5.2) 2.9 (2.7, 3.1) 1.74 (1.63, 1.86) 2.1 (1.9, 2.4) 1613 (1442, 1784) 161 (144, 178) 10.5% 32.0%
Any respiratory
condition
9.6 (9.3, 9.8) 7.0 (6.7, 7.2) 1.37 (1.31, 1.43) 2.6 (2.3, 2.9) 1941 (1691, 2191) 194 (169, 219) 12.6% 19.1%
†All differences in RTI-related mortality rates between winter and summer are statistically significant, Likelihood ratio test p < 0.001 for all ages.
*Range is estimated using the lower and upper end of the 95% confidence interval for the rate difference.
**Using point estimate for excess RTI-related deaths. Total non-injury deaths in winter by age group: 28–264 days = 6244, 1–4 years = 3056, 5–18 years = 6046.
***Using point estimate for excess RTI-related or any respiratory condition related deaths.
Total deaths by age group for RTIs only: 28–264 days = 1512, 1–4 years = 1411, 5–18 years = 2116.
Total deaths by age group for any respiratory condition: 28–264 days = 4219, 1–4 years = 2129, 5–18 years = 3821.
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Figure 3 Circular plot of monthly RTI-related mortality rates by age group (per 100,000 population). The distance from the centre of the
circle to the edge is proportional to the mortality rate.
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most common chronic conditions among children who
died with RTIs; 64.6% of children whose deaths were RTI-
related had a neurological sensory condition (Table 2). Of
the 4483 children with one or more chronic conditions
whose death was RTI-related, 75.2% had chronic conditions
from two or more of the eight chronic condition groups.
Of the 4483 children who died with RTIs and chronic
conditions, 74.7% (3349 children) died in winter. This was
significantly lower than among children who died with
RTIs but without chronic conditions, among whom 79.7%
(443 of 556 children) died in winter (χ2 test p = 0.01),
although the absolute difference in proportions was small.
Discussion
There has been no decline in RTI-related mortality in chil-
dren aged one year and above since 2001, despite signifi-
cant declines in all-cause non-injury deaths. We estimated
that an average of 161 excess RTI-related deaths occurred
each winter in children aged 28 days to 18 years in England.
This excess accounts for 32% of all RTI-related deaths.Although the highest mortality rates from RTIs in winter
were found in children aged between one and 11 months,
children aged between one and four years experienced the
highest number of excess winter RTI-related deaths as a
proportion of all RTI-related deaths. 89% of children who
died from RTIs had a chronic condition; 65% had a neuro-
logical/sensory condition.
This was a large study of all deaths in children aged
28 days to 18 years in England during a ten year period.
Since deaths from RTIs are relatively rare in children
compared to the elderly, the population wide coverage
of the study was necessary to ensure sufficient cases to esti-
mate the number of RTI-related deaths with reasonable
precision.
We used linked data involving death certificates and hos-
pital admissions which allowed identification of deaths
where an RTI was severe enough to warrant recording on a
hospital database shortly preceding death, even if this was
not recorded on death certificates. Use of linked hospital
admission data increased the sensitivity of our analyses for
detecting RTI-related deaths and the presence of chronic
Figure 4 Circular plot of monthly mortality rates for any respiratory condition by age group (per 100,000 population). The distance
from the centre of the circle to the edge is proportional to the mortality rate.
Table 2 Number and percentage (in brackets) of children who died with RTIs*, by type of chronic condition and age
group
Mental/
behavioural
Cancer/
blood
Chronic
infections
Respiratory Endocrine/metabolic/renal/
digestive/genitourinary
Musculoskeletal/
skin
Neurological/
Sensory
Cardiac
28-364 days 33 (2.2) 161 (10.6) 36 (2.4) 554 (36.6) 487 (32.2) 208 (13.8) 799 (52.8) 544 (36.0)
n = 1512
1-4 years 229 (16.2) 257 (18.2) 38 (2.7) 623 (44.2) 642 (45.5) 227 (16.1) 952 (67.5) 339 (24.0)
n = 1411
5-18 years 530 (25.0) 496 (23.4) 68 (3.2) 889 (42.0) 870 (41.1) 575 (27.2) 1505 (71.1) 315 (14.9)
n = 2116
All ages 792 (15.7%) 914 (18.1) 142 (2.8) 2066 (41.0) 1999 (39.7) 1010 (20.0) 3256 (64.6) 1198 (23.8)
n = 5039
*RTI-related deaths are defined using the following ICD-10 codes: A37, J00-J22.
Note that percentages will add up to more than 100% since chronic condition groups are not mutually exclusive and children can have conditions from more
than one group.
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Through linkage, we were able to identify a further 1700
children (amounting to 34% of the total number of cases)
who had an RTI on their hospital record, but this was not
mentioned on the death certificate.
We identified relatively poor agreement between hospital
records and death certificates in recording of any respira-
tory condition (66.1% agreement for deaths in hospital and
73.2% agreement for deaths outside hospital). Poor agree-
ment between hospital records and death certificates has
been reported previously [22-24]. Data linkage provides a
method of validating the diagnostic information recorded
in these datasets, as well as a strategy to overcome some of
the under-recording of diagnoses on death certificates.
The estimate of the proportion of children who had an
RTI in the month before death is likely to be an underesti-
mate, as linkage was limited to hospital records. Further
linkage to primary care databases and to data on diagno-
ses and treatment provided in hospices would allow an
examination of the role of RTIs in children who died but
who had not had a hospital admission in the month before
death. However, there are currently no national-level pri-
mary care or hospice datasets available in England.
We could not compare differential risks of RTI-related
mortality according to type of chronic condition since we
did not have information on all children (alive and dead)
who were affected according to type of chronic condition.
Future studies using longitudinal hospital data from birth
in children are required. These can be used to estimate
RTI-related death rates according to type of chronic con-
dition and other determinants such as deprivation level,
birth weight and gestational age.
Although our method allowed us to estimate the num-
ber of children whose deaths were RTI-related, it was not
possible to determine whether a child died of an RTI. The
exact chronology of events is difficult to infer from hos-
pital databases, since dates of infection onset or diagnoses
were not available. Further linkage to laboratory datasets
would allow the quantification of deaths from specific
pathogens and more detailed validation of diagnostic cod-
ing. This would also allow characterisation and subana-
lyses of community and hospital acquired infections.
We inferred preventability using trends over time and
differences between winter and summer in RTI-related
mortality rates. The rate differencing technique used to
estimate excess winter RTI-related deaths was a crude
attempt to estimate the number of deaths that may be
preventable. However, the vast majority of children
whose deaths were RTI-related had a chronic condition,
and of them, 75% had conditions affecting more than
one body system, indicating complex health problems. It
is therefore unlikely that all of these deaths could be pre-
vented, even through the use of interventions that may
be highly effective in healthy children. In children withvery complex health problems, it is possible that antibiotic
treatment or influenza or pneumococcal vaccination may
only delay death, not prevent the death completely. Such a
‘harvesting’ effect has been described in relation to the
effect of extreme weather on respiratory mortality in adults,
[25] but there is little evidence regarding such effects in
children, most likely due to mortality being relatively rare
at younger ages. In addition, it is likely that the number of
excess winter deaths represents only a small proportion of
all preventable RTI deaths throughout the year. Case note
reviews of a subset of these deaths could help to determine
whether an RTI was likely to be the cause of the death and
whether an RTI-related death could have been delayed or
prevented.
Previous studies have focused on estimating the mortal-
ity burden of particular pathogens, including influenza
and RSV, using statistical models. Assuming the majority
of RTI-related deaths in children are due to those two
viruses, our results are broadly compatible with estimates
of influenza and RSV related deaths in England [6], al-
though our study included a later time period. The studies
by Pitman et al. [26] and Hardelid et al. [5] are not directly
comparable to ours as they also include neonates.
Chronic conditions have previously been recognised as
risk factors for severe outcomes of RTIs in children,
[27-30] but there is a lack of evidence regarding which
interventions are effective for these children [27-30]. For
example, Osterholm et al. [31] estimated that live attenu-
ated influenza vaccine (now recommended for children
aged two to four years in the UK) is 83% effective at pre-
venting confirmed influenza infection in healthy children.
However, there is scant evidence for vaccine effectiveness
in children with chronic conditions, particularly for pre-
venting deaths. Likewise, industry-funded trials have shown
that palivizumab reduces hospital admissions for RSV in
high risk children by 50%, but with no evidence of signifi-
cant reductions in mortality [32]. Pneumococcal vaccine ef-
fectiveness has been estimated at 75%, [33] however since
the case fatality rate for invasive pneumococcal disease is
around 4% in children, [34] the effect on mortality is likely
to be small.Conclusions
Over 500 RTI-related deaths occur in children in England
each year. Up to one third of these are related to seasonal
variation, and a subset may be preventable. Nearly 90% of
RTI-related deaths occur in children with chronic condi-
tions, and the highest incidence is in children aged less
than one year. Effective implementation of prevention and
treatment of RTIs is likely to lower the mortality burden
in children, particularly in younger children aged less than
five years. The use of routinely collected data offer the
possibility of regular assessment of mortality rates to
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public health and treatment interventions.
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